Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report
Open Access
- 13 August 2013
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 13 (1) , 120
Abstract
Background: Prepubertal gynecomastia is a rare condition and most frequently classified as idiopathic. In HIV-infected adults gynecomastia is a recognised but infrequent side-effect of antiretroviral treatment (ART) and mostly attributed to efavirenz use. Gynecomastia should be distinguished from pseudogynecomastia as part of the lipodystrophy syndrome caused by Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to avoid incorrect substitution of drugs. In the medical literature only five cases of prepubertal gynecomastia in children taking ART are described and underlying pathogenesis was unknown. The occurrence of adverse effects of ART may interfere with therapy adherence and long-term prognosis and for that reason requires attention. We report the first case of prepubertal gynecomastia in a young girl attributed to efavirenz use. Case presentation: A seven-year-old African girl presented with true gynecomastia four months after initiation on ART (abacavir, lamivudine, efavirenz). History, physical examination and laboratory tests excluded known causes of gynecomastia and efavirenz was considered as the most likely cause. Six weeks after withdrawal of efavirenz the breast enlargement had completely resolved. Conclusions: Efavirenz-induced gynecomastia may occur in children as well as in adults. With the increasing access to ART, the possibility of efavirenz-exposure and the potential occurrence of its associated side-effects may be high. In resource-poor settings, empirical change from efavirenz to nevirapine may be considered, providing no other known or alarming cause is identified, as efavirenz-induced gynecomastia can resolve quickly after withdrawal of the drug. Timely recognition of gynecomastia as a side-effect of efavirenz is important in order to intervene while the condition may still be reversible, to sustain adherence to ART and to maintain the sociopsychological health of the child.Keywords
This publication has 30 references indexed in Scilit:
- Safety and Tolerability of Antiretroviral Therapy Among HIV-Infected Children And Adolescents In UGANDAJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growthHIV Medicine, 2010
- Prepubertal unilateral gynecomastia: a report of two casesEuropean Journal of Plastic Surgery, 2010
- Gynaecomastia associated with highly active antiretroviral therapy (HAART)Journal of Radiology Case Reports, 2010
- Substitution of Nevirapine because of Efavirenz Toxicity in AIDS Clinical Trials Group A5095Clinical Infectious Diseases, 2010
- A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Efavirenz in the therapy of HIV infectionExpert Opinion on Drug Metabolism & Toxicology, 2009
- SEVERE GYNECOMASTIA IN AN AFRICAN BOY WITH PERINATALLY ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS INFECTION RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPYThe Pediatric Infectious Disease Journal, 2006
- Prepubertal gynaecomastia: aetiology, course and outcomeClinical Endocrinology, 2004
- Efavirenz-Associated Gynecomastia: Report of Five Cases and Review of the LiteratureThe Breast Journal, 2004